Disseminated aspergillosis in intensive care unit patients: An autopsy study

Journal of Chemotherapy

Volumn 15, Issue 1, 2003, Pages 71-75

  Dimopoulos, G ^a   Piagnerelli, M ^a   Berre J ^a   Eddafali, B ^a   Salmon, I ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Chronic obstructive pulmonary disease; Corticosteroids; Fungal colonization; Fungal infection

Indexed keywords

CORTICOSTEROID; FLUCONAZOLE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AUTOPSY; BACTERIAL COLONIZATION; CANDIDIASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEATH; FEMALE; GRANULOCYTOPENIA; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LUNG INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PATIENT; SPUTUM; SPUTUM CULTURE; UNIVERSITY HOSPITAL;

EID: 0037300941     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.1.71     Document Type: Article

References (37)

1. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247-1251.
2. Patterson TF, Kirkpatrick WR, White M et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. 13 Aspergillus Study Group. Medicine (Baltimore) 2000; 79: 250-260.
3. Bodey G, Bueltmann B, Duguid W et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11: 99-109.
4. Kaiser L, Huguenin T, Lew PD, Chapuis B, Pittet D. Invasive aspergillosis. Clinical features of 35 proven cases at a single institution. Medicine (Baltimore) 1998; 77: 188-194
5. Manuel RJ, Kibbler CC. The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 1998; 39: 95-109.
6. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
7. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608-615.
8. Janssen JJ, Strack vSR, van der Poest Clement EH, Ossenkoppele GJ, Thijs LG, Huijgens PC. Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med 1996; 22: 1315-1322.
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
10. Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Morb Mortal Wkly Rep 1997; 46: 1-79.
11. Elstad MR. Aspergillosis and lung defenses. Semin Respir Infect 1991; 6: 27-36.
12. Duong M, Ouellet N, Simard M, Bergeron Y, Olivier M, Bergeron MG. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis 1998; 178: 1472-1482.
13. Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994; 140 (Pt 9): 2475- 2479.
14. Karam GH, Griffin FM. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis 1986; 8: 357-363.
15. Tankanow L, Eichenhorn MS. Disseminated Strongyloides stercoralis and Aspergillus fumigatus presenting as diffuse interstitial pneumonitis in a steroid-dependent chronic obstructive pulmonary disease patient. Henry Ford Hosp Med J 1988; 36: 41-43.
16. Wiest PM, Flanigan T, Salata RA, Shlaes DM, Katzman M, Lederman MM. Serious infectious complications of corticosteroid therapy for COPD. Chest 1989; 95: 1180-1184.
17. Thommi G, Bell G, Liu J, Nugent K. Spectrum of invasive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease. South Med J 1991; 84: 828-831.
18. Crean JM, Niederman MS, Fein AM, Feinsilver SH. Rapidly progressive respiratory failure due to Aspergillus pneumonia: a complication of short-term corticosteroid therapy. Crit Care Med 1992; 20: 148-150.
19. Conesa D, Rello J, Valles J, Mariscal D, Ferreres JC. Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 1995; 29: 1235-1237.
20. Warnock DW. Fungal compplications of transplantation diagnosis, treatment and prevention. J Antimicrob Chemother 1995; 36 Suppl B: 73-90.
21. Andriole VT. Infections with Aspergillus species. Clin Infect Dis 1993; 17 Suppl 2: S481-S486.
22. Gottfredsson M, Cox GM, Perfect JR. Molecular methods for epidemiological and diagnostic studies of fungal infections. Pathology 1998; 30: 405-418.
23. Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 2002; 19: 743-755.
24. Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest 2002; 121: 1171-1176.
25. Donnelly JP. Symptoms and diagnosis of nosocornial fungal infections: State-of-the-art. Eur J Med Res 2002; 7: 192-199.
26. Marier R, Smith W, Jansen M, Andriole VT., A solid-phase radioimmunoassay for the measurement of antibody to Aspergillus in invasive aspergillosis. J Infect Dis 1979; 140: 771-779.
27. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257-260.
28. Andriole VT. Serodiagnosis of asgergillosis. In: Bennett JE, Hey RJ, Peterson PK, eds. New Strategies in Fungal Disease. New York: Churchill Livingstone. 1991: 245-256
29. Franquet T, Muller NL, Gimenez A, Domingo P, Plaza V, Bordes R. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients. Am J Roentgenol 2000; 174: 51-56.
30. Flynn PM, Shenep JL, Crawford R, Hughes WT. Use of abdominal computed tomography for identifying disseminated fungal infection in pediatric cancer patients. Clin Infect Dis 1995; 20: 964-970.
31. Caillot D, Casasnovas O, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139-147.
32. Subira M, Martino R, Franquet T et al. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors. Haematologica 2002; 87: 528-534.
33. Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br J Haematol 1994; 86: 754-760.
34. Rodrigues J, Niederman MS, Fein AM, Pai PB. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992; 93: 29-34.
35. Pittet D, Huguenin T, Dharan S et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 541-544.
36. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473-1475.
37. Bulpa PA, Dive AM, Garrino MG et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001; 27: 59-67.